Literature DB >> 12196095

Survival-promoting functions of 14-3-3 proteins.

S C Masters1, R R Subramanian, A Truong, H Yang, K Fujii, H Zhang, H Fu.   

Abstract

The 14-3-3 proteins are a family of phosphoserine/phosphothreonine-binding molecules that control the function of a wide array of cellular proteins. We suggest that one function of 14-3-3 is to support cell survival. 14-3-3 proteins promote survival in part by antagonizing the activity of associated proapoptotic proteins, including Bad and apoptosis signal-regulating kinase 1 (ASK1). Indeed, expression of 14-3-3 inhibitor peptides in cells is sufficient to induce apoptosis. Interestingly, these 14-3-3 antagonist peptides can sensitize cells for effective killing by anticancer agents such as cisplatin. Thus, 14-3-3 may be part of the cellular machinery that maintains cell survival, and targeting 14-3-3-ligand interactions may be a useful strategy to enhance the efficacy of conventional anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12196095     DOI: 10.1042/bst0300360

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  31 in total

Review 1.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes.

Authors:  Carol Mackintosh
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

2.  Protection from rapamycin-induced apoptosis by insulin-like growth factor-I is partially dependent on protein kinase C signaling.

Authors:  Kuntebommanahalli N Thimmaiah; John B Easton; Peter J Houghton
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

3.  Involvement of Stat3 in mouse brain development and sexual dimorphism: a proteomics approach.

Authors:  Fabio Di Domenico; Gabriella Casalena; Rukhsana Sultana; Jian Cai; William M Pierce; Marzia Perluigi; Chiara Cini; Alessandra Baracca; Giancarlo Solaini; Giorgio Lenaz; Jia Jia; Suzan Dziennis; Stephanie J Murphy; Nabil J Alkayed; D Allan Butterfield
Journal:  Brain Res       Date:  2010-09-25       Impact factor: 3.252

4.  Immunocytochemical detection of 14-3-3 in primary nervous system tumors.

Authors:  Wei-Dong Cao; Xiang Zhang; Jian-Ning Zhang; Zhi-Jun Yang; Hai-Ning Zhen; Guang Cheng; Bian Li; Dakuan Gao
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

5.  The ADP-stimulated NADPH oxidase activates the ASK-1/MKK4/JNK pathway in alveolar macrophages.

Authors:  Honglei Liu; Hongqiao Zhang; Karen E Iles; Alessandra Rinna; Gary Merrill; Junji Yodoi; Martine Torres; Henry Jay Forman
Journal:  Free Radic Res       Date:  2006-08

Review 6.  14-3-3ζ as a prognostic marker and therapeutic target for cancer.

Authors:  Christopher L Neal; Dihua Yu
Journal:  Expert Opin Ther Targets       Date:  2010-12       Impact factor: 6.902

7.  Analysis of differentially expressed proteins in cancerous and normal colonic tissues.

Authors:  Lay-Harn Gam; Chiuan-Herng Leow; Che Nin Man; Boon-Hui Gooi; Manjit Singh
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

8.  14-3-3s regulate fructose-2,6-bisphosphate levels by binding to PKB-phosphorylated cardiac fructose-2,6-bisphosphate kinase/phosphatase.

Authors:  Mercedes Pozuelo Rubio; Mark Peggie; Barry H C Wong; Nick Morrice; Carol MacKintosh
Journal:  EMBO J       Date:  2003-07-15       Impact factor: 11.598

9.  Increases in expression of 14-3-3 eta and 14-3-3 zeta transcripts during neuroprotection induced by delta9-tetrahydrocannabinol in AF5 cells.

Authors:  Jia Chen; Chun-Ting Lee; Stacie L Errico; Kevin G Becker; William J Freed
Journal:  J Neurosci Res       Date:  2007-06       Impact factor: 4.164

10.  Syndecan-1 (CD138) Suppresses Apoptosis in Multiple Myeloma by Activating IGF1 Receptor: Prevention by SynstatinIGF1R Inhibits Tumor Growth.

Authors:  DeannaLee M Beauvais; Oisun Jung; Yang Yang; Ralph D Sanderson; Alan C Rapraeger
Journal:  Cancer Res       Date:  2016-06-30       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.